INTRODUCTION
Ross procedure (RP) is therapeutic for patients with a diseased aortic valve with particular benefits in pediatric population due to hemodynamic advantages, adaptation to growth, and freedom from anti-coagulation. 1 In a systematic review of reports between 1967 and 2013 by Berdajs and colleagues, the overall survival was >90% over 10 years after Ross procedure. 2 In the same study, freedom from overall re-intervention over 10 years was superior to 93% in comparison to 10% re-operation rate with mechanical prosthesis and 30% with bioprosthesis. 2 First described by Donald Ross in 1967, 3 RP has undergone technical evolution to prevent the late complications associated with it. Initially, the modality used was subcoronary technique which includes implantation of free dissected leaflets of pulmonary root in a sub-coronary position in the aortic root. 3 However, because of technical complexity as well as failure due to structural valve deterioration, the procedure did not gain wide acceptance. 4 In late 1980s, invention of free-standing root replacement modality, which includes aortic root replacement with a pulmonary root autograft, brought a wider approval of the Ross procedure due to its relative less demanding nature. 4 Owing to the higher re-operation rate due to late aortic root dilation and rising aortic regurgitation even with this technique, 5 a number of techniques have evolved to support the autograft. These manipulations mainly are composed of stabilisation of autograft annulus and autograftsinotubular junction with Teflon patch or pericardium to avoid dilatation of these sites. 6 Other modifications that have been proposed in literature are wrapping the entire autograft externally with a tubular polyester graft to prevent aneurysmal enlargement of neo-aortic root or by the use of Dacron interposition graft. 7 The technique of insertion of pulmonary autograft in Ross procedure plays a key role in determining the need of autograft re-operation which is the principal limitation of this procedure. These techniques aim to stabilise the aortic root geometry and avoid pulmonary autograft dilatation that leads to subsequent development of aortic regurgitation (AR), a common means of late RP failure. Limited literature available regarding RP in local population merits the need of comprehensive review to assess operative and postoperative course in this population.
The objective of this report was to describe the outcome of two variations of Ross procedure.
METHODOLOGY
This case series was conducted at a tertiary care hospital, after receiving approval from Ethics Review Committee. The patient population reported includes all eight patients who underwent the Ross procedure during the 10 years duration between January 2007 and December 2016. All preoperative, surgical, and post-operative data were obtained from medical records of the patients.
All procedures were carried out by a single surgeon. Intraoperative transesophageal two-dimensional and color-flow Doppler echocardiography was performed to assess pulmonary valve competence and diameters of pulmonary root's annulus and sinuses. After heparanization, standard cardiopulmonary bypass was used. Blood cardioplegia (4°C) was given initially through aortic root and then via coronary ostia for myocardial protection. Transverse aortotomy was performed in all patients. In all cases, pulmonary autograft was used for aortic root replacements with coronary reimplantation. Continuous running suture technique was employed in all the patients. There were minimal differences between the aortic annulus and the autograft. Six patients received free standing total root replacement while two patients with mixed aortic stenosis and aortic regurgitation had Dacron tube (Vascutek, Terumo Cardiovascular Systems Inc, Ann Arbor, MI) interposed between the autograft and the ascending aorta to stabilise the autograft and prevent aneurysmal enlargement of neo-aortic root. Contegra bio prosthesis conduit was used in four patients and manually constructed composite valved conduit including a combination of PTFE (polytetrafluoroethelene) membrane and bovine pericardium in other four patients. Aortic cross clamp was removed after reconstruction of RVOT. At the end of procedure, competence of pulmonary autograft and RVOT conduit was confirmed by transesophageal echocardiography.
EVIDENCE-BASED REPORT

RESULTS
Demographic characteristics and dominant hemodynamic conditions are shown in Table I . The median age of patients was 14 years. Three patients had received previous cardiac surgeries. Two In this series, none of the patients underwent autograft replacement in the follow-up duration. Bacterial valve endocarditis or valve related thromboembolism was also not seen.
Echocardiography showed severe neo-aortic valve regurgitation in one patient on last follow-up. Three patients demonstrated trace AR and another two had mild AR on last follow-up visit. Trace pulmonary regurgitation was seen in two patients while mild RVOT obstruction with peak pulmonary gradients of 20 mm of mercury and 22 mm of mercury noticed in two patients. They were all asymptomatic with normal right ventricular function. None of the patients underwent re-operation for RVOT conduit failure in the follow-up duration.
DISCUSSION
Ross procedure in itself is a technically demanding procedure with greater cross-clamping time as compared to other aortic valve replacement techniques. In this series, two different techniques of Ross procedure were employed. These included free standing total root replacement and modified total root replacement using Dacron interposition graft to stabilise the autograft. The competency of autograft is enhanced by complete root replacement as it maintains the geometry of graft as well as remove all abnormal aortic root parts. Prior literature has indicated higher rates of aortic root dilatation and aortic regurgitation with free standing root replacement without autograft stabilisation. 5 Although in this series, the outcome of both techniques inclusive of mortality, neo-aorta deterioration, and RVOT conduit failure requiring reoperation were similar. However, it is difficult to compare these techniques in a short case series. These results necessitate the need to assess the results of various Ross procedure practices in larger studies to provide evidence for optimal technique to be implemented in this population.
Another aspect to focus is the use of types of conduits for right ventricular outflow tract reconstruction. RVOT is considered to be the 'weak link' of Ross procedure contributing to majority of re-operations. The wellestablished transcatheter techniques enable the patients to have longer freedom from re-operation now. Use of Contegra, a gluteraldehyde-preserved heterologous bovine internal jugular vein with a trileaflet venous valve, provides the benefit of easy suturing without need of proximal or distal extension and large availability of various sizes (12 to 22 millimeters internal diameter). 8 Long term durability of bovine jugular vein graft is reported in a prior study with freedom from reintervention upto 90% at seven years. 9 Another technique utilised was manually constructed composite valved conduit involving the use of PTFE membrane for constructing RVOT patch within bovine pericardial tube. The major benefit of PTFE membrane is its functionality for longer periods by evading tissue ingrowth leading to rates of freedom from re-operation ranging between 96% at one year, 89% at five years, and 82% at 10 years. 10 
CONCLUSION
The various techniques of Ross procedure utilising pulmonary autograft carry freedom from risks of anticoagulation, mortality, and RVOT conduit failure. All these benefits merit the evaluation of these technical varieties in larger studies assessing more practices with longer follow-up time duration to devise optimal strategy in younger adults.
